About Sky Chemi Pharma
Sky Chemi Pharma offers products and services including Active Pharmaceutical Ingredients and Excipients and Pellets.
- SectorsHealthcare
- Email••••••••
- Legal Name Sky Chemi Pharma Pvt. Ltd
- Date of Incorporation 26 Aug, 2014
- Jurisdiction Mumbai, Maharashtra, India
- Annual Revenue₹57.2 Lakh
FY 2024 · +1218% YoY
- Net Profit₹4 Lakh
FY 2024 · 7% margin
- EBITDA₹4.2 Lakh
FY 2024 · 7% margin
Associated legal entities of Sky Chemi Pharma
Sky Chemi Pharma operates through Sky Chemi-Pharma Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2024) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Sky Chemi-Pharma Private Limited CIN U33119MH2014PTC257599 | Active | 26 Aug 2014 | Mumbai, Maharashtra | ₹0.6 Cr | – | 3 | View details |
Products & Services of Sky Chemi Pharma
Sky Chemi Pharma offers a comprehensive portfolio of products and services, including Active Pharmaceutical Ingredients and Excipients and Pellets.
Active pharmaceutical ingredients are exported for use in various medical formulations, sourced from leading manufacturers.
Excipients and pellets are provided as part of the product range to support formulation needs in the pharmaceutical industry.
Board of directors of Sky Chemi-Pharma Private Limited (Sky Chemi Pharma)
Sky Chemi-Pharma Private Limited is the primary company behind Sky Chemi Pharma. The board of Sky Chemi-Pharma Private Limited currently have 3 directors; the longest-serving is Adesh Vijay Saple, appointed in 2014. 1 earlier director has ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Adesh Vijay Saple DIN 02294358 | Director | 26 Aug 2014 | 12 yrs 1 mo | Sky Chemi-Pharma Private Limited |
| Sharad Suresh Agarwal DIN 08979667 | Director | 01 Mar 2021 | 5 yrs 7 mo | Sky Chemi-Pharma Private Limited |
| Adnya Adesh Saple DIN 06777017 | Director | 01 Mar 2021 | 5 yrs 7 mo | Sky Chemi-Pharma Private Limited |
Financials of Sky Chemi Pharma
Figures of Sky Chemi-Pharma Private Limited, the primary company behind Sky Chemi Pharma, for FY 2024. Revenue was ₹57.2 Lakh (+1218% year on year). Net profit was ₹4 Lakh (7% margin). EBITDA was ₹4.2 Lakh (7% margin). Revenue has grown at a compounded annual rate of +81% over three years and -32% over five years.
- ₹57.2 LakhRevenue · FY 2024 · +1218% YoY
- ₹4 LakhNet profit · 7% margin
- ₹4.2 LakhEBITDA · 7% margin
- ₹1 LakhPaid-up capital
- +81%Revenue CAGR, 3 years
- -32%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Sky Chemi-Pharma Private Limited are on its company page.
Detailed financial statements for Sky Chemi Pharma
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Similar companies to Sky Chemi Pharma
10 companies that operate in the same segment as Sky Chemi Pharma (Pharmaceuticals & Distribution), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Pharmaceutical products are manufactured and marketed worldwide. | 1891 | Kenilworth, Warwickshire, United Kingdom | – | USD 64.93 B | 781 | |
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed. | 2014 | New York, New York, United States | USD 1.3 B | USD 8.26 M | 750 | |
Developer of pharmaceutical products for treating multiple diseases | 1980 | Thousand Oaks, California, United States | – | USD 33.23 B | 28,000 | |
Biopharmaceutical research and drug development are conducted globally by AbbVie. | 2012 | Chicago, Illinois, United States | – | USD 61.16 B | 55,000 | |
Traditional pharmaceutical medicines are developed for multiple health fields. | 1876 | United States | – | USD 65.18 B | 47,000 | |
Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others | 1987 | Foster City, California, United States | – | USD 29.45 B | 17,600 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
Treatments for anemia and fibrosis by exploiting connective tissue growth factor (CTGF) and hypoxia-inducible factor (HIF) biology. | 1993 | San Francisco, California, United States | USD 215.5 M | USD 29.62 M | 225 | |
Developer of medical devices, generic pharmaceuticals, and nutrition products | 1888 | Libertyville, Illinois, United States | – | USD 44.33 B | 3,710 | |
Medicines and health products are retailed through pharmacy outlets. | 2006 | Hyderabad, Telangana, India | USD 268.78 M | USD 734.57 M | 25,010 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Sky Chemi Pharma
The primary company behind Sky Chemi Pharma, Sky Chemi-Pharma Private Limited, reported revenue of ₹57.2 Lakh for FY 2024, up 1218% year on year.
Sky Chemi Pharma is recognized as an export-oriented company established in 2014 and headquartered in Mumbai, India. It is involved in the export of active pharmaceutical ingredients and various products such as capsules, liquids, tablets, I.V. fluids, injections, DC and pellets, and excipients to regions including Africa, Europe, the Middle East, and the UK. Expansion is being pursued into other areas like Latin America and the CIS region. The company is certified under ISO 9001:2015 and WHO-GMP, with a focus on quality and innovation in meeting medical requirements. Products are sourced directly from manufacturers and consolidated for efficient shipment at competitive prices.
Sky Chemi Pharma offers Active Pharmaceutical Ingredients and Excipients and Pellets.
Sky Chemi Pharma operates through Sky Chemi-Pharma Private Limited.
The legal entities of Sky Chemi Pharma currently have 3 directors, including Adesh Vijay Saple, Sharad Suresh Agarwal, Adnya Adesh Saple.